Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px
Document › Details

Bruker Corporation. (2/1/19). "Press Release: Bruker Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference". Billerica, MA.

Region Region San Francisco, CA
  Country United States (USA)
Organisations Organisation Bruker Corporation (Nasdaq: BRKR)
  Group Bruker Corporation (Group)
  Organisation 2 Murdoch University
Products Product J.P. Morgan 37th Annual Healthcare Conference 2019 San Francisco
  Product 2 AVANCE™-IVDr system
Index terms Index term Bruker Corp–JPMorgan Chase: investor conference, 201901 supply service Bruker presents at JP Morgan Healthcare Conference 2019
  Index term 2 Murdoch Univ–Bruker Corp: mass spectrometer, 2018 supply ordered timsTOF Pro LC/CCS/MS/MS system
Persons Person Laukien, Frank H. (Bruker 201204 President + CEO)
  Person 2 Herman, Gerald N. (Bruker Corp 201806– CFO before Interim CFO joined 12/16 as VP + Corp Controller before Parexel)
     


Bruker Corporation (NASDAQ: BRKR) announced today it will participate in the 37th annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO and Gerald Herman, CFO will present on behalf of the company on Monday, January 7th, 2019 at 9:00 AM Pacific Time.

A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at https://ir.bruker.com . A replay of the presentation will be posted in the "Events & Presentations" section of the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.

[ Presentation on 7 Jan accessed on 26th January 2019 via https://s22.q4cdn.com/617463959/files/doc_presentations/2019/01/JPM19HCC-BRKR-FINAL-04Jan19.pdf ]


About Bruker Corporation (NASDAQ: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.


Contact :

Miroslava Minkova
Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
E: Miroslava.Minkova@Bruker.com

   
Record changed: 2019-02-03

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Bruker Corporation (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px




» top